Erlotinib
Generic Name: erlotinib
Brand Names:
Erlotinib
Erlotinib is a prescription kinase inhibitor available as tablets in 25 mg, 100 mg, and 150 mg strengths for the treatment of certain cancers.
Overview
Erlotinib is a prescription kinase inhibitor available as tablets in 25 mg, 100 mg, and 150 mg strengths for the treatment of certain cancers.
Uses
Treatment of metastatic non-small cell lung cancer (NSCLC) with specific EGFR mutations.
Dosage
150 mg orally, on an empty stomach, once daily for NSCLC.
Frequently Asked Questions
What is Erlotinib used for?▼
Treatment of metastatic non-small cell lung cancer (NSCLC) with specific EGFR mutations.
Related Medications
Octinoxate, Octocrylene, Octisalate, And Avobenzone
octinoxate, octocrylene, octisalate, and avobenzone
Purpose Sunscreen
Alfalfad1, Absinthiumd4, Angusturad2, China Offd4, Cinnamond3, Illicium Anisd1, Nux Vomicad7
alfalfad1, absinthiumd4, angusturad2, china offd4, cinnamond3, illicium anisd1, nux vomicad7
Non-Standardized Food Allergenic Extract [EPC]
Uses Temporarily relieves occasional appetite loss, nausea, vomiting, decreased urination, puffy face, weight loss discomfort, paleness, and poor nutrient absorption.* *CLAIMS BASED ON TRADITIONAL HOMEOPATHIC PRACTICE, NOT ACCEPTED MEDICAL EVIDENCE, NOT FDA EVALUATED. This product is not intended to diagnose, treat, cure, or prevent any disease.
Atorvastatin Calcium, Film Coated
atorvastatin calcium, film coated
11 DESCRIPTION Atorvastatin is an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase. Atorvastatin calcium USP is [R-(R*, R*)]-2-(4-fluorophenyl)-ß,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid, calcium salt (2:1) trihydrate. The empirical formula of atorvastatin calcium is (C 33 H 34 FN 2 O 5 ) 2 Ca•3H 2 O and its molecular weight is 1209.42.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.